Allergan plc (NYSE:AGN)

172.49
Delayed Data
As of Jun 21
 -2.70 / -1.54%
Today’s Change
142.81
Today|||52-Week Range
256.80
+5.45%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$52.3B

Company Description

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded on in 1984 and is headquartered in Dublin, Ireland.

Contact Information

Allergan Plc
Clonshaugh Business & Tech. Park
Dublin Dublin D17 E400
P:3538622617000
Investor Relations:
(862) 261-7558

Employees

Shareholders

Other institutional45.88%
Mutual fund holders42.83%
Individual stakeholders0.30%

Top Executives

Brenton L. SaundersChairman, President & Chief Executive Officer
Wayne R. SwantonExecutive Vice President-Global Operations
Matthew M. WalshChief Financial Officer & Executive Vice President
C. David NicholsonChief Research & Development Officer
Jonathon KellermanGlobal Chief Compliance Officer & Executive VP